Skip to main content
. Author manuscript; available in PMC: 2012 Nov 21.
Published in final edited form as: Stat Commun Infect Dis. 2011 Oct;3(1):1037. doi: 10.2202/1948-4690.1037

Figure 5.

Figure 5

Potential-harm boundary comparing a vaccine regimen versus placebo. For each infection diagnosed within 18 months of randomization from the 7th to the 99th (x) the boundary is reached if at least y of the infections were assigned to the vaccine arm. The red and blue lines illustrate the analyses at the 30th and 60th infection, with stopping boundary ≥ 22 and ≥ 40 of the infections in the vaccine arm, respectively.